Sign in
4/A

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-21-019668

EVP, R&D & CMO gave up 524 shares (to pay taxes)

  • EVP, R&D & CMO acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

O'Neill Gilmore Neil · EVP, R&D & CMO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-28 Shares withheld for taxes : show line 1 in the form −524 $86.97 $45,572 13,546 D
2021-03-03 Grant or award : show line 2 in the form +15,000 28,546 D
Loading xslF345X03/doc4a.xml…